[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 20, Issue 2 (4-2022) ::
Int J Radiat Res 2022, 20(2): 491-498 Back to browse issues page
Dynamic contrast enhanced MRI Pharmacokinetic parameter histogram analysis in diagnosis of malignant prostatic lesions
X.M. Ma, L.L. Wang, P. Wang, Y.Q. Ma, We.W. Zhang, J.W. He, G. Huang, L.P. Zhao, J.L. Ren, Z.Q. Shi
Radiology Department, Gansu Provincial hospital, Donggang West Road, Lanzhou, Gansu Province, China 730000 , knee0999@163.com
Abstract:   (137 Views)
Background: To differentiate prostate cancer and benignprostatichyperplasia by WAHPP (the whole lesion histogram analysis of the pharmacokineticparameters) of dynamic contrast-enhancedMRI (DCE-MRI). Materials and Methods: Totally 62 patients with elevated prostate specific antigen (PSA) (> 4 ng/ml) were grouped as prostate cancer (PCa) group (n=33) and benign prostatic hyperplasia (BPH) group (n=29) based on transrectal ultrasound (TRUS)-guided random biopsy diagnosis and their WAHPP- Ktrans (constant is transferred from the blood plasma to the extracellular extravascular (EE) space), Kep (back into blood plasma at a steady rate from EE space), Ve (EE volume fraction) and Vp (fractional blood plasma volume) were compared. Results: WHAPP shows the 5th percentile and entropy of Ktrans, 5th/10th/25th/50th/75th/90th/95th percentiles, mean value and entropy of Kep, 5th percentile and uniformity of Ve, 5th/10th/25th/50th/75th percentiles, Vp had a considerably greater mean value and entropy in PCa than in BPH (p0.05). The 90th percentile of Kep's maximum AUC (area under the curve) was 0.764, according to receiver operating characteristic (ROC) study, the Youden index 0.5507, the sensitivity 75.76%, and the specificity 79.31%. Conclusion: Ktrans, Kep, and Ve of WHAPP canbe used to quantify prostate DCE-MRI. The 90th percentile of Kep possibly will be the best indicator for the differential diagnosis of malignant and BPH.
Keywords: Histogram, pharmacokinetic parameters, dynamic contrast-enhanced MRI, prostate cancer, benign prostatic hyperplasia.
Full-Text [PDF 2709 kb]   (88 Downloads)    
Type of Study: Original Research | Subject: Radiation Biology
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ma X, Wang L, Wang P, Ma Y, Zhang W, He J, et al . Dynamic contrast enhanced MRI Pharmacokinetic parameter histogram analysis in diagnosis of malignant prostatic lesions. Int J Radiat Res. 2022; 20 (2) :491-498
URL: http://ijrr.com/article-1-4287-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 20, Issue 2 (4-2022) Back to browse issues page
International Journal of Radiation Research
Persian site map - English site map - Created in 0.04 seconds with 32 queries by YEKTAWEB 4419